Roubaix Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.43M Buy
+54,555
New +$7.62M 3% 9
2025
Q3
Sell
-26,459
Closed -$3.29M 67
2025
Q2
$3.29M Sell
26,459
-8,412
-24% -$1.07M 1.58% 31
2025
Q1
$4.44M Buy
+34,871
New +$5.37M 2.31% 18
2024
Q3
Sell
-14,020
Closed -$1.77M 61
2024
Q2
$1.77M Buy
+14,020
New +$2.2M 1.12% 39

Other funds holding RGEN

Roubaix Capital's RGEN Position: Q1 2026 in Review

Roubaix Capital opened a new position in Repligen (RGEN) in Q1 2026: 54,555 shares worth $6.43M. The stake represents 3% of the portfolio and ranks #9 among its holdings. This is a return to the name: Roubaix Capital previously reported a position in RGEN as recently as Q2 2025.

Roubaix Capital first reported a position in RGEN in Q2 2024 and has held it in 4 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Roubaix Capital held 54,555 shares of Repligen worth $6.43M as of Q1 2026.
  • Repligen was a new Roubaix Capital position in Q1 2026.
  • Repligen made up 3% of Roubaix Capital's portfolio in Q1 2026, its #9 holding.
  • Roubaix Capital first reported a position in Repligen in Q2 2024 and has held it in 4 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Roubaix Capital's 13F filing for Q1 2026, filed 6 May 2026.